145 related articles for article (PubMed ID: 38095784)
1. Association of radiotherapy for prostate cancer and second primary colorectal cancer: a US population-based analysis.
Tang W; Zhou LJ; Zhang WQ; Jia YJ; Ge MW; Hu FH; Chen HL
Tech Coloproctol; 2023 Dec; 28(1):14. PubMed ID: 38095784
[TBL] [Abstract][Full Text] [Related]
2. Second primary colorectal cancer after the initial primary colorectal cancer.
Yang L; Xiong Z; Xie QK; He W; Liu S; Kong P; Jiang C; Xia X; Xia L
BMC Cancer; 2018 Sep; 18(1):931. PubMed ID: 30261873
[TBL] [Abstract][Full Text] [Related]
3. The impact of age at the time of radiotherapy for localized prostate cancer on the development of second primary malignancies.
Krasnow RE; Rodríguez D; Nagle RT; Mossanen M; Kibel AS; Chang SL
Urol Oncol; 2018 Nov; 36(11):500.e11-500.e19. PubMed ID: 30249519
[TBL] [Abstract][Full Text] [Related]
4. Second primary colorectal cancer in adults: a SEER analysis of incidence and outcomes.
Lun W; Luo C
BMC Gastroenterol; 2023 Jul; 23(1):253. PubMed ID: 37495987
[TBL] [Abstract][Full Text] [Related]
5. The risk and survival outcome of subsequent primary colorectal cancer after the first primary colorectal cancer: cases from 1973 to 2012.
Yang J; Du XL; Li S; Wu Y; Lv M; Dong D; Zhang L; Chen Z; Wang B; Wang F; Shen Y; Li E; Yi M; Yang J
BMC Cancer; 2017 Nov; 17(1):783. PubMed ID: 29166866
[TBL] [Abstract][Full Text] [Related]
6. Association of Radiotherapy for Rectal Cancer and Second Gynecological Malignant Neoplasms.
Guan X; Wei R; Yang R; Lu Z; Liu E; Zhao Z; Chen H; Yang M; Liu Z; Jiang Z; Wang X
JAMA Netw Open; 2021 Jan; 4(1):e2031661. PubMed ID: 33416884
[TBL] [Abstract][Full Text] [Related]
7. Risk of second primary malignancies associated with radiotherapy in prostate cancer patients: competing risk analysis.
Wu Y; Li Y; Han C; Chong Y; Kang K; Liu Z; Zhang F
Future Oncol; 2022 Feb; 18(4):445-455. PubMed ID: 35018785
[TBL] [Abstract][Full Text] [Related]
8. Risk and prognosis of second corpus uteri cancer after radiation therapy for pelvic cancer: A population-based analysis.
Yu G; Wei R; Li S; Wang Y; Liu H; Chen T; Guan X; Wang X; Jiang Z
Front Oncol; 2022; 12():957608. PubMed ID: 36249002
[TBL] [Abstract][Full Text] [Related]
9. External Beam Radiotherapy Increases the Risk of Bladder Cancer When Compared with Radical Prostatectomy in Patients Affected by Prostate Cancer: A Population-based Analysis.
Moschini M; Zaffuto E; Karakiewicz PI; Andrea DD; Foerster B; Abufaraj M; Soria F; Mattei A; Montorsi F; Briganti A; Shariat SF
Eur Urol; 2019 Feb; 75(2):319-328. PubMed ID: 30293908
[TBL] [Abstract][Full Text] [Related]
10. Radiation therapy at the end of life: a population-based study examining palliative treatment intensity.
Kress MA; Jensen RE; Tsai HT; Lobo T; Satinsky A; Potosky AL
Radiat Oncol; 2015 Jan; 10():15. PubMed ID: 25582217
[TBL] [Abstract][Full Text] [Related]
11. Ascertainment of postprostatectomy radiotherapy for prostate cancer in the Surveillance, Epidemiology, and End Results database.
Wang K; Sheets NC; Basak R; Chen RC
Cancer; 2016 Oct; 122(19):3069-74. PubMed ID: 27352280
[TBL] [Abstract][Full Text] [Related]
12. The characteristics of bladder cancer after radiotherapy for prostate cancer.
Abern MR; Dude AM; Tsivian M; Coogan CL
Urol Oncol; 2013 Nov; 31(8):1628-34. PubMed ID: 22575239
[TBL] [Abstract][Full Text] [Related]
13. Increased Burden of Second Bladder Cancer and Rectal Cancer in Prostate Cancer Treated With Radiotherapy: Results From Surveillance, Epidemiology, and End Results.
Lin J; Zhan X; Chen R; Chen T; Jiang M; Li Y; Liu X; Chen G; Fu B
Cancer Control; 2023; 30():10732748231177544. PubMed ID: 37196346
[TBL] [Abstract][Full Text] [Related]
14. External Beam Radiation Therapy With a Brachytherapy Boost Versus Radical Prostatectomy in Gleason Pattern 5 Prostate Cancer: A Population-Based Cohort Study.
Wang C; Kishan AU; Kamrava M; Steinberg ML; King CR
Int J Radiat Oncol Biol Phys; 2017 Aug; 98(5):1045-1052. PubMed ID: 28721887
[TBL] [Abstract][Full Text] [Related]
15. Risk and prognosis of secondary thoracic cancers after radiation therapy for esophageal cancer.
Yi H; Li S; Lin Y; Li F; Wang S; Jin D; Lv Z; Fu L; Mao Y
J Gastroenterol Hepatol; 2023 Jun; 38(6):930-939. PubMed ID: 36811199
[TBL] [Abstract][Full Text] [Related]
16. Risk and prognosis of secondary esophagus cancer after radiotherapy for breast cancer.
Sun Q; Chen Y; Li T; Ni B; Zhu X; Xu B; Li J
Sci Rep; 2023 Mar; 13(1):3968. PubMed ID: 36894590
[TBL] [Abstract][Full Text] [Related]
17. Incidence and risk outcomes of second primary malignancy of patients with post-operative colorectal cancer.
Yang J; Wu F; An H; Gan H
Int J Colorectal Dis; 2023 Mar; 38(1):88. PubMed ID: 36995483
[TBL] [Abstract][Full Text] [Related]
18. Propensity-weighted long-term risk of urinary adverse events after prostate cancer surgery, radiation, or both.
Jarosek SL; Virnig BA; Chu H; Elliott SP
Eur Urol; 2015 Feb; 67(2):273-80. PubMed ID: 25217421
[TBL] [Abstract][Full Text] [Related]
19. Neighborhood and Individual Socioeconomic Disadvantage and Survival Among Patients With Nonmetastatic Common Cancers.
Cheng E; Soulos PR; Irwin ML; Cespedes Feliciano EM; Presley CJ; Fuchs CS; Meyerhardt JA; Gross CP
JAMA Netw Open; 2021 Dec; 4(12):e2139593. PubMed ID: 34919133
[TBL] [Abstract][Full Text] [Related]
20. Inverse probability of treatment-weighted competing risks analysis: an application on long-term risk of urinary adverse events after prostate cancer treatments.
Bolch CA; Chu H; Jarosek S; Cole SR; Elliott S; Virnig B
BMC Med Res Methodol; 2017 Jul; 17(1):93. PubMed ID: 28693428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
